iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Sandy Spring Bank

Sandy Spring Bank decreased its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 2.6% in the 4th quarter, HoldingsChannel reports. The fund owned 18,028 shares of the financial services provider’s stock after selling 475 shares during the quarter. Sandy Spring Bank’s holdings in iShares Biotechnology ETF were worth $2,383,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Darwin Wealth Management LLC purchased a new position in iShares Biotechnology ETF in the third quarter worth $29,000. HHM Wealth Advisors LLC raised its position in iShares Biotechnology ETF by 200.0% in the fourth quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock worth $30,000 after acquiring an additional 150 shares in the last quarter. VSM Wealth Advisory LLC purchased a new position in iShares Biotechnology ETF in the fourth quarter worth $30,000. Bradley & Co. Private Wealth Management LLC purchased a new position in iShares Biotechnology ETF in the fourth quarter worth $32,000. Finally, Newbridge Financial Services Group Inc. purchased a new position in iShares Biotechnology ETF in the fourth quarter worth $33,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

iShares Biotechnology ETF stock opened at $132.74 on Friday. The firm has a market capitalization of $6.05 billion, a price-to-earnings ratio of 27.83 and a beta of 0.77. iShares Biotechnology ETF has a fifty-two week low of $123.60 and a fifty-two week high of $150.57. The stock’s fifty day moving average is $136.21 and its two-hundred day moving average is $139.49.

iShares Biotechnology ETF Increases Dividend

The company also recently announced a dividend, which will be paid on Friday, March 21st. Shareholders of record on Tuesday, March 18th will be issued a $0.1212 dividend. This is a positive change from iShares Biotechnology ETF’s previous dividend of $0.06. The ex-dividend date is Tuesday, March 18th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.